Biopath Diagnostics Private Limited
About Biopath Diagnostics Private Limited
Data last updated:
Biopath Diagnostics Private Limited is a private limited company based in Nashik, Maharashtra, India. It operates in the medical and laboratory equipment segment of the healthcare sector. It was incorporated on 08 June 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2018PTC310502.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Yashwant Balkrushna Patte and Reshma Keshavrao Dalal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Row House No.10 Kesar Park Co – Op Soc S. No. 489/A Plot No. 62 And 69 Satpur, Nashik, Maharashtra, India – 422101.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.12 Cr, a growth of 36% compared to the previous year. For the same year it recorded a net profit of ₹3.13 Lakh (net margin 1%) and EBITDA of ₹18.49 Lakh (EBITDA margin 5.9%). Revenue has grown at a compounded annual rate (CAGR) of 11% over three years and 53% over five years.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressRow House No.10 Kesar Park Co – Op Soc S. No. 489/A Plot No. 62 And 69 Satpur, Nashik, Maharashtra, India – 422101
- IndustryHealthcare, Medical & Laboratory Equipment
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Auditor Details of Biopath Diagnostics Private Limited
Biopath Diagnostics Private Limited is audited by Amit Adulkar and Co. for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Amit Adulkar and Co. | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Biopath Diagnostics Private Limited
Biopath Diagnostics has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Yashwant Balkrushna Patte | Director | 08 Jun 2018 | 8 Years 3 Months | Current |
| Reshma Keshavrao Dalal Also directs: BD Bio-Pathlabs Private Limited | Director | 08 Jun 2018 | 8 Years 3 Months | Current |
| Budhdadas Shamrao Ukey | Director | 08 Jun 2018 | 8 Years 3 Months | Current |
Financials of Biopath Diagnostics Private Limited FY 2025 filings available
Biopath Diagnostics Private Limited reported revenue of ₹3.12 Cr (up 36% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Biopath Diagnostics Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 53% over five years, including 36% growth in the latest year. EBITDA rose 181% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Biopath Diagnostics Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹18.49 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹3.13 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Biopath Diagnostics Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.9% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 1% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Biopath Diagnostics are in the company report.
Financial statements from FY 2019
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Biopath Diagnostics Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Biopath Diagnostics Private Limited
Biopath Diagnostics Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Biopath Diagnostics Private Limited
Employment history and EPFO contributions of people linked to Biopath Diagnostics.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Biopath Diagnostics Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Biopath Diagnostics Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Biopath Diagnostics Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Biopath Diagnostics Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Biopath Diagnostics Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Biopath Diagnostics Private Limited
Frequently Asked Questions about Biopath Diagnostics Private Limited
Biopath Diagnostics is an active private limited company based in Nashik, Maharashtra, India. The company works in medical and laboratory equipment, within the healthcare industry. It was incorporated on 08 June 2018 (8+ years old) and is registered under CIN U74999MH2018PTC310502.
Biopath Diagnostics reported revenue of ₹3.12 Cr for FY 2025 (up 36% YoY).
Biopath Diagnostics has 3 current directors:
- Yashwant Balkrushna Patte - Director
- Reshma Keshavrao Dalal - Director
- Budhdadas Shamrao Ukey - Director
Biopath Diagnostics reported a net profit of ₹3.13 Lakh (net margin 1%) and EBITDA of ₹18.49 Lakh (EBITDA margin 5.9%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Biopath Diagnostics is 11% over three years and 53% over five years. In the latest year (FY 2025) revenue rose 36%. CAGR is the steady yearly rate that links the first and the last year.
The CIN (Corporate Identification Number) of Biopath Diagnostics is U74999MH2018PTC310502. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Biopath Diagnostics was incorporated on 08 June 2018, making it 8+ years old. It is registered with the Registrar of Companies, Mumbai.
The registered office of Biopath Diagnostics is at Row House No.10 Kesar Park Co – Op Soc S. No. 489A Plot No. 62 And 69 Satpur, Nashik, Maharashtra, India – 422101.
Biopath Diagnostics has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh.